huang
qiaob
microvascular
permeabl
one
import
patholog
event
pathogenesi
trauma
burn
injuri
massiv
leakag
fluid
vascular
space
lead
lose
blood
plasma
decreas
effect
circulatori
blood
volum
result
format
sever
tissu
edema
hypotens
even
shock
especi
sever
burn
injuri
fluid
resuscit
valid
approach
sustain
patient
blood
volum
long
time
due
lack
overal
profound
understand
mechan
vascular
hyperperm
respons
emerg
concept
recent
year
socal
barrier
stabil
mediat
play
posit
role
prevent
increas
vascular
permeabl
mediat
may
releas
respons
proinflammatori
mediat
serv
restor
endotheli
barrier
function
stabil
mediat
import
even
quiescent
state
preserv
basal
vascular
permeabl
low
level
review
introduc
mediat
reveal
underli
signal
mechan
endotheli
barrier
enhanc
process
key
word
permeabl
endothelium
vascular
mediat
complex
receptor
cyclic
amp
protein
human
e
ndotheli
barrier
disrupt
microvascular
hyperperm
contribut
pathogenesi
variou
acut
chronic
inflammatori
diseas
releas
circul
permeabilityincreas
cytokin
mediat
thrombin
bradykinin
histamin
radic
oxygen
speci
vascular
endotheli
growth
factor
vegf
tumor
necrosi
lipopolysaccharid
lp
etc
increas
vascular
permeabl
primarili
format
intercellular
gap
endotheli
cell
ec
postcapillari
venul
normal
ec
tightli
connect
variou
protein
regul
organ
intercellular
junction
complex
adheren
tight
junction
bind
cytoskelet
protein
cytoplasm
interact
partner
allow
transfer
intracellular
signal
govern
barrier
function
ec
normal
inflammatori
condit
stimul
intrins
extrins
proinflammatori
mediat
interendotheli
junction
open
allow
paracellular
fluid
passag
agonistsinduc
hyperperm
usual
revers
process
recoveri
endotheli
barrier
function
could
emerg
reanneal
previous
open
interendotheli
junction
strengthen
adhes
ec
extracellular
matrix
result
reequilibrium
compet
contractil
adhes
forc
gener
cytoskelet
protein
adhes
molecul
also
emerg
concept
recent
year
socal
stabil
mediat
play
posit
role
enhanc
interendotheli
junction
connect
prevent
increas
vascular
permeabl
endogen
mediat
includ
classic
antiedema
reagent
glucocorticoid
cyclic
adenosin
monophosph
camp
adenosin
triphosph
recent
found
mediat
intermedin
imd
sphingosin
activ
protein
c
apc
well
kinas
immunoglobulinlik
egflik
domain
system
mediat
may
gener
releas
respons
proinflammatori
mediat
serv
restor
endotheli
barrier
function
exogen
reagent
statin
also
found
function
endotheli
permeabl
stabil
review
introduc
mediat
reveal
underli
signal
mechan
endotheli
barrier
enhanc
process
glucocorticoid
glucocorticoid
wellknown
antiedema
drug
clinic
although
util
limit
due
advers
effect
increas
risk
secondari
infect
glucocorticoid
report
reinforc
barrier
via
signal
transduct
pathway
origin
endotheli
intracellular
glucocorticoid
receptor
act
respons
element
control
express
steroid
respons
target
gene
correspond
protein
recent
public
reveal
dexamethason
prevent
cell
permeabl
glucocorticoid
receptor
transactiv
nuclear
factorkappab
transrepress
cell
cultur
rat
retina
dexamethason
hydrocortison
also
act
increas
endotheli
express
mrna
protein
level
tight
junction
molecul
zona
occludin
cultur
cell
diabet
anim
multipl
sclerosi
patient
dexamethason
coordin
upregul
express
downregul
vegf
express
brain
astrocyt
pericyt
lead
promot
integr
ec
stabil
bloodbrain
barrier
also
approv
dexamethason
suppress
vegf
intercellular
adhes
express
diabet
rat
correl
effect
retin
vascular
permeabl
leukocyt
accumul
glucocorticoid
wellment
mani
clinic
practic
guidelin
due
effect
steroid
stabil
endotheli
barrier
function
glucocorticoid
recommend
treatment
variou
inflammatori
diseas
sepsi
shock
acut
lung
injuri
asthma
arthriti
macular
edema
etc
battl
sever
acut
respiratori
syndrom
sar
proper
use
corticosteroid
confirm
critic
sar
result
lower
mortal
shorter
hospit
stay
applic
corticosteroid
restrict
clinic
due
advers
effect
surviv
sepsi
campaign
guidelin
recommend
intraven
hydrocortison
given
adult
patient
septic
shock
blood
pressur
confirm
poorli
respons
fluid
resuscit
vasopressor
therapi
system
system
includ
receptor
regul
permeabl
part
modul
small
gtpase
rhoamedi
pathway
activ
myosinactin
filament
factin
interact
almost
play
opposit
role
regul
format
stress
fiber
tether
forc
adjac
cell
gener
junction
transmembran
protein
particular
vecadherincatenin
complex
one
best
describ
endogen
cell
signal
system
help
maintain
vascular
integr
matur
agonist
ec
ligand
endotheliumspecif
receptor
tyrosin
kinas
ligandreceptor
system
share
mani
proangiogen
properti
vegf
ec
howev
contrast
vegf
protect
blood
vessel
increas
plasma
leakag
contribut
stabil
mobil
confluent
ec
transloc
cellcel
contact
assembl
uniqu
homotyp
transcomplex
opposit
cell
includ
vascular
endotheli
phosphotyrosin
phosphatas
veptp
complex
preferenti
activ
akt
serin
kinas
phosphoryl
endotheli
nitric
oxid
synthas
eno
enosderiv
nitric
oxid
central
increas
permeabl
respons
vegf
inhibit
product
via
phosphoryl
eno
residu
threonin
protein
kinas
c
zeta
respons
least
part
inhibit
vegfstimul
endotheli
permeabl
report
also
show
receptor
activ
one
small
gprotein
rho
mdia
sequest
src
result
inhibit
src
stabil
vecadherin
interendotheli
adheren
junction
receptor
phosphoryl
signal
via
activ
rhogtpaseactiv
protein
enzym
bring
rhoa
back
inact
gdpbound
form
result
reduc
factin
stress
fiber
format
endotheli
permeabl
mccarter
et
al
report
system
exert
strong
protect
effect
rat
transgen
mice
model
lpsinduc
acut
lung
injuri
origin
experi
studi
patient
show
attenu
respons
endothelium
inflamm
hyperperm
apoptosi
vasoreact
stimuli
clinic
show
level
reduc
septic
nonsept
critic
ill
patient
circul
level
ratio
use
predict
develop
acut
respiratori
distress
syndrom
sepsi
critic
ill
patient
numer
evid
show
anim
model
overexpress
administr
exogen
inhibit
ec
activ
reduc
vascular
leakag
prevent
lpsinduc
decreas
blood
pressur
cardiac
output
attenu
lpsinduc
increas
lung
water
subsequ
improv
surviv
rate
yet
explor
effect
applic
system
patient
sure
potenti
therapeut
target
wide
express
peptid
secret
ec
vascular
smooth
muscl
cell
cardiac
myocyt
well
human
leukocyt
etc
mediat
activ
bind
complex
receptor
compos
calcitonin
receptor
likereceptor
crlr
associ
receptor
activitymodifi
delet
function
gene
receptor
gene
lack
g
proteincoupl
receptor
modul
protein
result
format
extrem
gener
edema
disrupt
vascular
integr
suggest
strong
barrier
stabil
function
demonstr
increas
transendotheli
electr
resist
ec
improv
endotheli
barrier
function
activ
camp
signal
pathway
upregul
tight
junction
protein
inhibit
amactiv
camppka
pathway
cyclosporin
impair
brain
endotheli
barrier
function
administr
attenu
extravas
albumin
plasma
fluid
rat
septic
shock
reduc
mortal
imd
recent
identifi
peptid
target
crlr
also
call
much
stronger
effect
stabil
endotheli
barrier
also
activ
camppka
via
complex
imd
reduc
thrombin
hydrogen
peroxideand
hypoxiainduc
endotheli
hyperperm
basal
condit
newest
report
show
imd
differenti
effect
macromolecul
permeabl
ec
differ
vascular
bed
increas
permeabl
rat
coronari
microvascular
ec
reduc
permeabl
human
umbil
vein
endotheli
cell
huvec
rat
aortic
ec
potenti
enhanc
endotheli
barrier
function
downregul
express
proinflammatori
cytokin
imd
consid
novel
treatment
target
attenu
acut
lung
injuri
sepsi
show
applic
mitig
edemacharacter
lung
injuri
loss
plasma
fluid
rat
model
septic
shock
still
need
intens
endeavor
imd
could
translat
bench
bed
produc
phosphoryl
sphingosin
abund
lipid
mediat
plasma
regul
numer
physiolog
function
vascular
immun
cell
present
blood
nanomolar
micromolar
concentr
deliv
high
densiti
lipoproteinassoci
apolipoprotein
receptor
varieti
cell
type
differ
speci
differ
receptor
express
profil
littl
main
receptor
express
ec
propos
balanc
express
activ
ec
help
maintain
physiolog
function
especi
barrier
function
ec
appropri
physiolog
level
caus
activ
result
strengthen
barrier
integr
ec
induc
rac
signal
pathway
lack
harm
endotheli
barrier
function
administr
anim
model
burn
acut
lung
injuri
attenu
vascular
hyperperm
result
enhanc
endotheli
junction
integr
format
stronger
cortic
actin
ring
depress
synthesi
enzym
sphingosin
kinas
inhibitor
n
ndimethylsphingosin
caus
obviou
disorgan
junction
structur
cultur
huvec
suppress
lyas
respons
degrad
protect
lpsinduc
murin
acut
lung
injuri
also
evid
show
intracellular
induc
barrier
enhanc
via
similar
cellular
signal
pathway
independ
receptor
although
experiment
demonstr
strong
effect
endotheli
barrier
protect
usag
clinic
limit
fact
excess
induc
activ
lead
disrupt
interendotheli
junction
evok
rhoarock
pathway
thu
final
barrier
regul
efficaci
depend
balanc
express
activ
differ
receptor
ec
activ
strengthen
pathway
benefici
prevent
vascular
leakag
apc
apc
natur
anticoagul
play
import
role
coagul
homeostasi
inactiv
procoagul
factor
va
viiia
besid
cytoprotect
function
antiinflammatori
antiapoptot
effect
endotheli
barrier
protect
apc
dynam
augment
ec
cortic
actin
ring
decreas
format
transcellular
stress
fiber
associ
decreas
paracellular
gap
improv
monolay
integr
correspond
ec
barrier
protect
inact
protein
c
bind
specif
receptor
surfac
ec
call
endotheli
protein
c
receptor
lead
activ
akt
transactiv
receptor
mention
activ
receptor
mediat
vascular
endotheli
barrier
enhanc
also
demonstr
apc
activ
via
mechan
requir
sequenti
order
endotheli
protein
c
receptor
proteaseactiv
egf
receptor
select
enhanc
signal
strengthen
junction
complex
reduc
vascular
permeabl
recombin
form
human
apc
rhapc
drotrecogin
alfa
activ
known
commerci
xigri
approv
us
feder
drug
administr
treatment
sever
sepsi
associ
high
risk
mortal
demonstr
rhapc
reduc
mortal
sever
septic
patient
larg
recombin
human
activ
protein
c
worldwid
evalu
sever
sepsi
prowess
trial
rhapc
withdrawn
european
medicin
agenc
octob
th
due
lack
efficaci
treatment
sepsi
reassess
prowess
shock
trial
sinc
remind
basic
research
clinic
physician
barrier
enhanc
effect
quit
clear
apc
advers
influenc
fibrolysi
may
rais
risk
bleed
hamper
clinic
applic
statin
statin
reductas
inhibitor
lower
serum
cholesterol
notic
statin
exhibit
myriad
clinic
benefit
includ
enhanc
vascular
integr
increas
tight
junction
protein
decreas
intercellular
adhes
express
simvastatin
prevent
damag
cerebr
endotheli
tight
junction
neutrophil
infiltr
parenchyma
exert
antiedemat
effect
reduc
neurolog
deficit
cerebr
edema
well
bloodbrain
barrier
permeabl
h
traumat
brain
injuri
demonstr
lovastatin
attenu
rhoa
activ
induc
myosin
light
chain
mlc
dephosphoryl
basal
condit
oppos
increas
phosphoryl
mlc
myosin
phosphatas
target
respons
thrombin
glycocalyx
key
contribut
endotheli
barrier
function
chargeselect
exclus
plasma
protein
meuwes
et
al
report
shortterm
statin
therapi
partial
restor
endotheli
glycocalyx
reduc
patient
heterozyg
famili
hypercholesterolemia
statin
wide
use
prescript
drug
barrier
enhanc
effect
desir
accompani
benefit
patient
physician
vascular
leakag
earli
patholog
event
develop
relat
diseas
arteriosclerosi
cardiac
diseas
hypertens
etc
except
abovement
barrier
stabil
factor
lot
mediat
barrier
enhanc
function
includ
prostaglandin
pg
e
pgi
essenti
metabol
homeostasi
regul
hormon
insulin
actinbind
vasodilatorstimul
phosphoprotein
etc
substanc
found
stabil
function
endotheli
permeabl
futur
abovement
barrierstabil
mediat
reli
cyclic
nucleotid
second
messeng
camp
pathway
realiz
vascular
protect
function
process
enhanc
endotheli
barrier
function
camp
critic
signal
molecul
util
variou
barrierstabil
mediat
variou
barrierstabil
mediat
directli
increas
concentr
camp
result
enhanc
endotheli
barrier
function
inhibit
phosphodiesteras
increas
endotheli
camp
stabil
endotheli
barrier
attenu
increas
acut
inflammatori
vascular
permeabl
hand
sever
barrierdisrupt
compon
appear
increas
permeabl
reduc
format
camp
lpsmediat
barrier
breakdown
also
relat
decreas
intracellular
camp
activ
activ
adenyl
cyclas
subsequ
increas
camp
common
consequ
receptor
activ
varieti
cell
cyclosporin
impair
brain
endotheli
barrier
function
inhibit
amactiv
camppka
pathway
imd
induc
attenu
endotheli
hyperperm
mediat
activ
camppka
via
complex
well
mediat
pge
pgi
stabil
endotheli
barrier
function
partli
increas
camp
level
activ
guanosin
triphosphatas
gtpase
exchang
factor
call
exchang
protein
activ
camp
epac
could
directli
activ
camp
also
reveal
induc
activ
rasrel
tighten
cellcel
contact
arrang
factin
endotheli
junction
area
report
demonstr
camp
signal
strictli
compartment
wherea
camp
eman
transmembran
ac
activ
barrierenhanc
target
filamin
camp
eman
solubl
ac
activ
barrierdisrupt
target
tau
gtpase
rho
famili
regul
cell
adhes
cytoskelet
reorgan
also
import
regul
endotheli
barrier
function
rhoa
via
effector
rho
kinas
rock
thought
predominantli
destabil
endotheli
barrier
properti
promot
mlcdepend
contract
stress
fibr
reduc
vecadherinmedi
adhes
anoth
small
gprotein
rho
famili
play
import
role
regul
actin
cytoskelet
organ
well
known
requir
mainten
endotheli
barrier
function
activ
drive
cortactin
transloc
cell
membran
coloc
myosin
light
chain
kinas
regul
mlc
phosphoryl
cytoskelet
rearrang
mammoto
et
al
elucid
signal
pathway
activ
rho
famili
gtpase
organ
cytoskeleton
junctionfortifi
arrang
consequ
decreas
permeabl
endothelium
protect
vascular
leakag
vivo
even
increas
camp
requir
mediat
effect
endotheli
function
downstream
signal
camp
strengthen
interendotheli
adheren
junction
interestingli
exogen
reagent
simvastatin
induc
cortic
arrang
factin
improv
barrier
function
also
inhibit
geranylgeranyl
coval
modif
enabl
transloc
small
gtpase
rho
rac
cell
membran
figur
give
simplifi
schemat
imag
major
signal
pathway
endotheli
barrier
regul
enhanc
pathway
emphas
signal
also
reveal
particip
signal
transduct
regul
vascular
barrier
function
controversi
effect
protein
kinas
czeta
found
play
role
thrombininduc
increas
vascular
permeabl
contribut
inhibit
vegfinduc
endotheli
permeabl
vitro
list
barrier
stabil
mediat
signal
bear
notion
mind
socal
barrier
enhanc
mediat
might
differenti
effect
vascular
endotheli
permeabl
depend
activ
receptor
signal
pathway
cellular
compart
signal
locat
vascular
bed
increas
vascular
leakag
remain
critic
event
develop
inflammatori
diseas
sometim
seriou
even
lifethreaten
clinic
challeng
set
sever
burn
injuri
acut
lung
injuri
respiratori
distress
syndrom
novel
treatment
need
although
specif
extent
endotheli
barrierprotect
properti
yet
defin
pharmacolog
approach
includ
use
barrier
enhanc
mediat
apc
statin
etc
may
repres
novel
therapeut
strategi
possibl
reinforc
barrier
enhanc
pathway
also
provid
anoth
train
thought
attenu
increas
vascular
permeabl
